The safety of available treatments options for neuroendocrine tumors
Sign Up to like & getrecommendations! Published in 2017 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2017.1354984
Abstract: ABSTRACT Introduction: Neuroendocrine neoplasms (NEN) represent a heterogeneous group of malignancies generally characterized by low proliferation and indolent course. However, about half of the newly diagnosed cases are metastatic and require long-term systemic therapies. Areas… read more here.
Keywords: treatments options; options neuroendocrine; safety available; safety ... See more keywords